p53 overexpression as a prognostic indicator in endometrial carcinoma

European Journal of Gynaecological Oncology

Volumn 24, Issue 3-4, 2003, Pages 275-278

  Ozalp, S ^a   Yalcin, O T ^a   Tanir, H Mete ^a   Kabukcuoglu, S ^a   Erol, G ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Endometrial carcinoma; p53 overexpression; Prognosis

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CYTOLOGY; ENDOMETRIUM CARCINOMA; FEMALE; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0038352179     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Harris R.C.: "The 1995 Walter Hubert Lecture-molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumor suppressor gene". Br. J. Cancer, 1996, 73, 261.
2. Burton J.L., Stewart R.L., Heatley M.K., Royds J.A., Wells M.: "p53 overexpression, p21 expression and the apoptotic index in endometrioid carcinoma". Histopathology, 1999, 35 (3), 221.
3. Heffner H.M., Freedman A.N., Asirwatham J.E., Lele S.B.: "Prognostic significance of p53, PCNA and c-erbB-2 in endometrial carcinoma". Eur. J. Gynaecol. Oncol., 1999, 20 (1), 8.
4. Ozsaran A.A., Turker S., Dikmen Y., Ethan Y., Itil I., Terek C., Ozdemir N.: "p53 staining as aprognostic indicator in endometrial carcinoma". Eur. J. Gynaecol. Oncol., 1999, 20 (2), 156.
5. Coronado P.J., Vidart J.A., Lopez-Asenjo J.A., Fasero M., Furiobacete V., Magrina J., Escudero M.: "p53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression". Eur. J. Obstet. Gynecol. Reprod. Biol., 2001, 98 (1) 103.
6. Geisler J.P., Wiemann M.C., Zhou Z., Miller G.A., Geisler H.E.: "p53 as a prognostic indicator in endometrial cancer". Gynecol. Oncol., 1996, 61, 245.
7. Athassiadou P., Pertakakou A.N., Lioussi A., Nakaoulou L., Zerva C., Dimopoulos A., Athanassiades P.: "Prognostic significance of p53,bcl-2 and EGFR in carcinoma of the endometrium". Acta Cytol., 1999, 43 (6), 1039.
8. Cherchi P.L., Marras V., Capobianco G., Ambrossini G., Piga M.D., Fadda G.M. et al.: "Prognostic value of p53, c-erb-B2 and MIB-I in endometrial carcinoma". Eur. J. Gynecol. Oncol., 2001, 22(6), 451.
9. Geisler J.P., Geisler H.E., Wieman M.C., Zhou Z., Miller G.A., Crabtree W.: "p53 expression as a prognostic indicator of 5 year survival in endometrial carcinoma". Gynecol. Oncol., 1999, 74 (3), 468.
10. Ambros R.A., Sheehan C.E., Kallakuri B.V., Ros J.S., Malfetano J., Punowich E., Figge J.: "MDM-2 and p53 protein expression in the histologic subtypes of endometrial carcinoma". Mol. Pathol., 1996, 9 (12), 1165.
11. Salvesen H.B., Iversen O.E., Akslen L.A.: "Prognostic significance of angiogenesis and KI-67, p53, and p21 expression: a population-based endometrial carcinoma study". J. Clin. Oncol., 1999, 17 (5), 1382.
12. Powell B., Soong R., Grieu F., Knowles S., Hammond I., Iacopetta B.: "p53 protein overexpression is a prognostic indicator of poor survival in stage I endometrial carcinoma". Int. J. Oncol., 1999, 14 (1), 175.
13. Giatromanolaki A., Sivridis E., Koukourakis M.I., Harris A.L., Gatter K.C.: "Bcl-2 and p53 expression in stage I endometrial carcinoma". Anticancer Res., 1998, 18 (5B), 2689.
14. Sakuragi N., Salah-eldin A.E., Watari H., Itoh T., Inoue S., Moriuchi T., Fujimoto S.: "Bax, Bcl-2 and p53 expression in endometrial cancer". Gynecol. Oncol., 2002, 86 (3), 288.
15. Risinger J.I., Hayes K., Maxwell G.L., Carney M.E., Dodge R.K., Barrett J.C., Berchuck A.: "PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics". Clin. Cancer Res., 1998, 4 (12), 3005.
16. Lungren C., Auer G., Frankel B., Moberger B., Nilsson B., Nordstrom B.: "Nuclear DNA content, proliferative activity, and p53 expression related to clinical and histopathologic features in endometrial carcinoma". Int. J. Gynecol. Cancer, 2002, 12 (1), 110.
17. Ohkouchi T., Sakuragi N., Watari H., Nomura E., Todo Y., Yamada H., Fujimoto S.: "Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endometrial carcinoma". Am. J. Obstet. Gynecol., 2002, 187 (2), 353.